Publication & Citation Trends
Most Cited Works
Publications
28 total
Abstract 6311: ABBV-400: An ADC delivering a novel topoisomerase 1 inhibitor to c-Met-positive solid tumors
Cited by 9
OpenAlex
A “Prozone-Like” Effect Influences the Efficacy of the Monoclonal Antibody ABT-700 against the Hepatocyte Growth Factor Receptor
Cited by 4
OpenAlex
ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both <i>MET</i> –Amplified and c-Met–Overexpressing Tumors, Irrespective of <i>MET</i> Pathway Dependence PDF
Cited by 133
OpenAlex
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification PDF
Cited by 61
OpenAlex
Genetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells PDF
Cited by 28
OpenAlex
Imidazo[2,1-b]thiazoles: Multitargeted inhibitors of both the insulin-like growth factor receptor and members of the epidermal growth factor family of receptor tyrosine kinases PDF
Cited by 56
OpenAlex
Substituted 4-amino-1H-pyrazolo[3,4-d]pyrimidines as multi-targeted inhibitors of insulin-like growth factor-1 receptor (IGF1R) and members of ErbB-family receptor kinases PDF
Cited by 25
OpenAlex
Research Topics
Liver physiology and pathology
(11)
PI3K/AKT/mTOR signaling in cancer
(9)
HER2/EGFR in Cancer Research
(8)
Radiopharmaceutical Chemistry and Applications
(4)
Cancer-related Molecular Pathways
(3)
Frequent Co-Authors
Affiliations
AbbVie (United States)
Abbott (United States)
Abbott Fund